Perimenopausal Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Meet the diagnostic criteria of both Traditional Chinese Medicine (TCM) and Western medicine for perimenopausal syndrome; 2)No use of any hormone-related medications within the past three months; 3)Signed an informed consent form and voluntarily agreed to participate in the intervention methods of this program.
Exclusion criteria
Exclusion criteria: 1)Unexplained vaginal bleeding or non-natural menopause; 2)Use of hormone replacement therapy (HRT) or other medications related to the condition within the past 3 months; 3)Concurrent severe organic diseases endocrine disorders or cardiovascular liver kidney or respiratory system diseases; 4)Presence of organic uterine lesions such as polycystic ovary syndrome (PCOS) malignant tumors severe cervical erosion post-hysterectomy etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improved Kupperman score scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Menopause-specific Quality of Life(MENQOL);Inflammatory Factor;Safety Observation Indicators (blood routine urine routine liver and kidney function adverse event records);Vasoconstrictor Factor;Ovarian volume;Pittsburgh sleep quality index;TCM Pattern Identification Questionnaire;Antral Follicle Counting;Menstrual Health Assessment Scale;Neurotransmitter levels;serum reproductive hormone levels; | — |
Countries
China
Contacts
Hubei University of Chinese Medicine